Cooper Companies Inc (NYSE:COO) – Investment analysts at William Blair boosted their FY2018 earnings estimates for shares of Cooper Companies in a research report issued to clients and investors on Friday. William Blair analyst B. Weinstein now expects that the medical device company will post earnings of $11.46 per share for the year, up from their prior estimate of $10.75. William Blair also issued estimates for Cooper Companies’ FY2019 earnings at $12.32 EPS.

COO has been the topic of several other reports. Jefferies Group reiterated a “buy” rating and issued a $250.00 price target on shares of Cooper Companies in a research report on Tuesday, September 12th. Stephens reiterated an “equal weight” rating and issued a $250.00 price target (up from $235.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Zacks Investment Research upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $265.00 price target on the stock in a research report on Tuesday, October 10th. KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a research report on Monday, August 28th. Finally, Piper Jaffray Companies boosted their price target on shares of Cooper Companies from $265.00 to $280.00 and gave the stock an “overweight” rating in a research report on Friday, September 1st. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $259.70.

Shares of Cooper Companies (NYSE:COO) traded down $5.47 during trading on Monday, reaching $224.19. 637,059 shares of the company’s stock traded hands, compared to its average volume of 430,109. The company has a current ratio of 2.41, a quick ratio of 1.26 and a debt-to-equity ratio of 0.36. Cooper Companies has a 12-month low of $172.83 and a 12-month high of $256.39. The company has a market capitalization of $11,182.45, a PE ratio of 23.50, a PEG ratio of 1.85 and a beta of 0.54.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The firm had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. During the same period in the previous year, the business earned $2.28 earnings per share. Cooper Companies’s revenue for the quarter was up 8.3% compared to the same quarter last year.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Advisory Services Network LLC raised its holdings in Cooper Companies by 30.6% during the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after buying an additional 107 shares during the period. YorkBridge Wealth Partners LLC grew its stake in Cooper Companies by 2.1% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after acquiring an additional 11 shares in the last quarter. Acrospire Investment Management LLC grew its stake in Cooper Companies by 50.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock valued at $144,000 after acquiring an additional 200 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in Cooper Companies during the 3rd quarter valued at about $163,000. Finally, Penserra Capital Management LLC grew its stake in Cooper Companies by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock valued at $211,000 after acquiring an additional 102 shares in the last quarter. Hedge funds and other institutional investors own 96.79% of the company’s stock.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.60% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/fy2018-eps-estimates-for-cooper-companies-inc-coo-increased-by-analyst/1762210.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.